Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

​ Conditions: Primary Central Nervous System Lymphoma (PCNSL); Diffuse Large B Cell Lymphoma (DLBCL)

Interventions: Drug: Pomalidomide; Drug: PD-1 / PD-L1 monoclonal antibody; Drug: XPO1 inhibitor

Sponsors: Beijing Tongren Hospital

Recruiting Conditions: Primary Central Nervous System Lymphoma (PCNSL); Diffuse Large B Cell Lymphoma (DLBCL)
Interventions: Drug: Pomalidomide; Drug: PD-1 / PD-L1 monoclonal antibody; Drug: XPO1 inhibitor
Sponsors: Beijing Tongren Hospital
Recruiting